Rare Disease. Commercial Precision. 23 Years Inside the Rooms Where These Decisions Are Made.
Brian Baldari is the founder and principal of Resilient Performance Group LLC, a life sciences strategic advisory practice serving biotech and biopharma organizations with pipeline-stage assets across rare disease, complement biology, renal, hematology, and specialty therapeutic areas.
He brings 23 years of commercial and medical affairs leadership in these
categories — not analyzing these launches from the outside, but owning them.
That is not a market research perspective.
That is operating judgment, applied on behalf of the companies that need it most.
Brian Baldari's complete 23-year career record and therapeutic area experience is documented at brianbaldari-nj.com.
"I have run commercial strategy for assets in this space. I was not an
observer. I was the person accountable for the number. I know where these
plans break, because I have had to fix them."
The differentiator that defines Resilient Performance Group LLC is direct:
Brian Baldari has led commercial strategy for launches in rare renal disease, complement biology, and adjacent therapeutic areas — as a General Manager carrying the P&L, not as a consultant observing from a project room.
That means he knows structurally how these decisions get made: which endpoints can actually carry a promotional message, what a payer does when a fourth entrant arrives, where a launch plan quietly fails eighteen months before anyone notices.
Pattern recognition earned from the inside, applied to your program.
This is not a credential claim. It is judgment you can only get from someone who has carried the number.
Resilient Performance Group LLC provides general management-level advisory across nine capability areas:
Rare Disease Commercial Strategy
— launch readiness, patient identification, market access, field force deployment, and KOL engagement for ultra-rare and rare disease pipeline assets.
Complement Biology Market Intelligence
— category dynamics, competitive positioning, and commercial differentiation for complement inhibitor programs.
Renal and Nephrology Launch Planning
— rare renal and ultra-rare nephrology commercialization, including IgA nephropathy, C3G, and complement-mediated renal disease.
Market Access and Payer Strategy
— payer landscape assessment, value dossier development, HEOR narrative, and access pathway planning for specialty and ultra-rare assets.
Medical Affairs Alignment
— MSL deployment strategy, medical communication planning, and clinical evidence gap analysis in support of pre-launch and launch-stage programs.
Pipeline Portfolio Optimization
— portfolio prioritization frameworks, indication sequencing, and lifecycle management strategy across multi-asset rare disease portfolios.
Global Launch Strategy
— international commercialization sequencing, ex-US market entry strategy, and global brand positioning for assets with multi-geography launch timelines.
Commercial Readiness Assessment
— structured evaluation of commercial readiness across people, process, and infrastructure for organizations approaching pivotal trial readouts.
Business Development and Licensing Support
— commercial diligence, market opportunity sizing, and deal framework support for in-licensing, out-licensing, and acquisition evaluations.
The leadership development philosophy that runs in parallel with this advisory practice is at brianbaldariresilexec.com.
14 Blockbuster Brands Launched · 23 Years Healthcare Leadership · Rare Renal · Complement Biology · Ophthalmology · Cardiometabolics · Hematology · Neuroscience · Women's Health · GLP-1
ABOUT THE ADVISOR
Brian Baldari — Pharm.D. | MBA | 23-Year Life Sciences Leader
Brian earned his Doctor of Pharmacy at Rutgers University and his MBA in Healthcare from George Washington University. He began his career as a Medical Science Liaison at Watson Pharmaceuticals, where he built his clinical foundation before transitioning into commercial leadership. Over the next two decades he rose through successive Director roles at Boehringer Ingelheim — where he held five consecutive Director-level positions across global pipeline marketing, managed markets, and HCP marketing — before ascending to Executive Director and then VP and Senior General Manager at Novartis, where he led a 250-person rare disease business unit and earned the Novartis President's Award as a Top 5 US Leader.
Today he leads Resilient Performance Group LLC from Brick Township, Ocean County, New Jersey — providing fractional general management advisory to biotech and biopharma organizations that need proven commercial leadership without full-time overhead
The full personal narrative behind this career is at brianbaldarinj.com.
The advisor who has been on the other side of the table.
Fourteen brands launched. Three therapeutic areas where Brian's prior insider experience is now the strategic asset your program needs. The organizations competing against you built their strategies with people like Brian at the table. Now you can have that same perspective working for you.
The Full Career Record
23 years. 14 brands. Rare renal. Complement biology. The complete professional credential documentation.
Brian Baldari's full credential record
Executive Coaching
The same leadership system Brian built for himself — now deployed for Directors and VPs in healthcare and enterprise IT.
ResilExec® executive coaching for healthcare leaders → resilexec.com
The Full Story
Career, character, athletic identity, community roots, and the purpose that connects it all.
Brian Baldari's complete professional and personal narrative → brianbaldarinj.com
Approaching a readout?
If the science is ahead of the commercial plan, that is the conversation
to have.
Direct enquiries reach Brian, not an intake queue.
Brick Township, New Jersey · US and global engagements
"The forecast is not the hard part. Defending it to a board that has already seen three of these go sideways — that is the hard part."
BRIAN BALDARI
Pharm.D. | MBA | Life Sciences Leader
Founder and Principal, Resilient Performance Group LLC
Founder, ResilExec® Coaching
"My purpose is to improve the health and wellbeing of my global family — by advancing therapies that address chronic, life-threatening, and rare diseases, by developing the leaders who execute those missions, and by coaching individuals to perform at the highest level of their human potential."
© 2026 Resilient Performance Group LLC · All Rights Reserved · resilexec.com
LinkedIn
Instagram
Facebook
Youtube